We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > DiaMedica

News List

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors firstwordpharma
July 16, 2021
DiaMedica Therapeutics Inc. a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Company's Board of Directors.
DiaMedica pulls off IPO to fund midphase stroke trial fiercebiotech
December 28, 2018
DiaMedica Therapeutics has wrapped up its IPO. The offering gives DiaMedica the cash to take its lead candidate through phase 2 trials in acute ischemic stroke (AIS) and chronic kidney disease (CKD).....
DiaMedica, Ahon Pharma sign license agreement for stroke treatment biospectrumasia
September 29, 2018
Under the terms of the license agreement, DiaMedica is entitled to receive an upfront payment of $5 million, consisting of $500,000 on signing...